Ginsenoside Rg3 primarily inhibits cell migration by reducing the protein levels of MMPs such as MMP-2, MMP-7, and MMP-9, and by obstructing the EMT process in cancer cells [652, 668–670]. The gene discussed is MMP9; the disease is cancer.